(Q47891585)

6 February 2018

title

Autoimmunity: CTLA-4: a key protein in autoimmunity (English)

1 reference

6 February 2018

author

Jagadeesh Bayry

series ordinal

1

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2009

1 reference

6 February 2018

Nature Reviews Rheumatology

published in

1 reference

6 February 2018

volume

5

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

244-245

1 reference

6 February 2018

CTLA-4 control over Foxp3+ regulatory T cell function

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Regulatory T cells and immune tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Drug Insight: abatacept for the treatment of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.77

31 March 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.77

1 reference

6 February 2018

1 reference

6 February 2018